Swiss Medtech Voices Brexit Business Fears, Prepares For EU Regs
Executive Summary
Switzerland is small in geographic terms, but a major player in medtech. It has been among the first to detail its economic concerns tied to the UK's plans to leave the European Union.
You may also be interested in...
Brexit: What Now For Device Notified Bodies, CE Marks And The Future MDR/IVDR?
While the UK and the EU struggle to comprehend the full implications of the UK's decision to leave the EU, Amanda Maxwell considers the implications for the implementation of the future EU regulations on medical devices and IVDs, including the question mark that hangs over the future of UK notified bodies.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.